1287 related articles for article (PubMed ID: 12637076)
1. Herpes zoster guideline of the German Dermatology Society (DDG).
Gross G; Schöfer H; Wassilew S; Friese K; Timm A; Guthoff R; Pau HW; Malin JP; Wutzler P; Doerr HW
J Clin Virol; 2003 Apr; 26(3):277-89; discussion 291-3. PubMed ID: 12637076
[TBL] [Abstract][Full Text] [Related]
2. The role of antivirals in the management of neuropathic pain in the older patient with herpes zoster.
Lilie HM; Wassilew S
Drugs Aging; 2003; 20(8):561-70. PubMed ID: 12795624
[TBL] [Abstract][Full Text] [Related]
3. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults.
Beutner KR; Friedman DJ; Forszpaniak C; Andersen PL; Wood MJ
Antimicrob Agents Chemother; 1995 Jul; 39(7):1546-53. PubMed ID: 7492102
[TBL] [Abstract][Full Text] [Related]
4. Brivudin compared with famciclovir in the treatment of herpes zoster: effects in acute disease and chronic pain in immunocompetent patients. A randomized, double-blind, multinational study.
Wassilew S;
J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):47-55. PubMed ID: 15649191
[TBL] [Abstract][Full Text] [Related]
5. Management of herpes zoster (shingles) and postherpetic neuralgia.
Stankus SJ; Dlugopolski M; Packer D
Am Fam Physician; 2000 Apr; 61(8):2437-44, 2447-8. PubMed ID: 10794584
[TBL] [Abstract][Full Text] [Related]
6. Herpes zoster: diagnostic, therapeutic, and preventive approaches.
Bader MS
Postgrad Med; 2013 Sep; 125(5):78-91. PubMed ID: 24113666
[TBL] [Abstract][Full Text] [Related]
7. Oral antivirals revisited in the treatment of herpes zoster: what do they accomplish?
Nikkels AF; Piérard GE
Am J Clin Dermatol; 2002; 3(9):591-8. PubMed ID: 12444801
[TBL] [Abstract][Full Text] [Related]
8. Open-label study of valacyclovir 1.5 g twice daily for the treatment of uncomplicated herpes zoster in immunocompetent patients 18 years of age or older.
Madkan VK; Arora A; Babb-Tarbox M; Aboutlabeti S; Tyring S
J Cutan Med Surg; 2007; 11(3):89-98. PubMed ID: 17511925
[TBL] [Abstract][Full Text] [Related]
9. Brivudin (bromovinyl deoxyuridine).
Keam SJ; Chapman TM; Figgitt DP
Drugs; 2004; 64(18):2091-7; discussion 2098-9. PubMed ID: 15341504
[TBL] [Abstract][Full Text] [Related]
10. Varicella-zoster virus.
Arvin AM
Clin Microbiol Rev; 1996 Jul; 9(3):361-81. PubMed ID: 8809466
[TBL] [Abstract][Full Text] [Related]
11. Oral brivudin in comparison with acyclovir for herpes zoster: a survey study on postherpetic neuralgia.
Wassilew SW; Wutzler P;
Antiviral Res; 2003 Jun; 59(1):57-60. PubMed ID: 12834861
[TBL] [Abstract][Full Text] [Related]
12. Valaciclovir: a review of its use in the management of herpes zoster.
Ormrod D; Goa K
Drugs; 2000 Jun; 59(6):1317-40. PubMed ID: 10882165
[TBL] [Abstract][Full Text] [Related]
13. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
[TBL] [Abstract][Full Text] [Related]
14. [Update in the treatment of herpes zoster].
España A; Redondo P
Actas Dermosifiliogr; 2006 Mar; 97(2):103-14. PubMed ID: 16595111
[TBL] [Abstract][Full Text] [Related]
15. Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentered study.
Wassilew SW; Wutzler P;
Antiviral Res; 2003 Jun; 59(1):49-56. PubMed ID: 12834860
[TBL] [Abstract][Full Text] [Related]
16. Recommendations for the management of herpes zoster.
Dworkin RH; Johnson RW; Breuer J; Gnann JW; Levin MJ; Backonja M; Betts RF; Gershon AA; Haanpaa ML; McKendrick MW; Nurmikko TJ; Oaklander AL; Oxman MN; Pavan-Langston D; Petersen KL; Rowbotham MC; Schmader KE; Stacey BR; Tyring SK; van Wijck AJ; Wallace MS; Wassilew SW; Whitley RJ
Clin Infect Dis; 2007 Jan; 44 Suppl 1():S1-26. PubMed ID: 17143845
[TBL] [Abstract][Full Text] [Related]
17. Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older.
Tyring SK; Beutner KR; Tucker BA; Anderson WC; Crooks RJ
Arch Fam Med; 2000; 9(9):863-9. PubMed ID: 11031393
[TBL] [Abstract][Full Text] [Related]
18. Oral brivudin vs. intravenous acyclovir in the treatment of herpes zoster in immunocompromised patients: a randomized double-blind trial.
Wutzler P; De Clercq E; Wutke K; Färber I
J Med Virol; 1995 Jul; 46(3):252-7. PubMed ID: 7561799
[TBL] [Abstract][Full Text] [Related]
19. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group.
Tyring S; Barbarash RA; Nahlik JE; Cunningham A; Marley J; Heng M; Jones T; Rea T; Boon R; Saltzman R
Ann Intern Med; 1995 Jul; 123(2):89-96. PubMed ID: 7778840
[TBL] [Abstract][Full Text] [Related]
20. Antiviral therapy of herpes simplex and varicella-zoster virus infections.
Wutzler P
Intervirology; 1997; 40(5-6):343-56. PubMed ID: 9675639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
